Lateral Flow Assay Development Using Dyes Across the Spectrum
Download this whitepaper to discover assay development tools that can help you to image various dyes with different excitation and emission wavelengths, achieve a high degree of photostability as well as detect the presence of proteins including SARS-CoV-2's spike protein.
Non-Invasive Monitoring of Nonalcoholic Steatohepatitis
Nonalcoholic steatohepatitis (NASH) is an aggressive form of nonalcoholic fatty liver disease (NAFLD), a liver condition that is characterized by liver steatosis accompanied by liver cell injury and inflammation.
Detection Of Low-Abundance Serum Proteins Associated With Prediabetes For Predictive And Prognostic Purposes
Download this whitepaper to uncover predicting disease onset via clinical biomarkers as well as other potential applications in diabetes research.
Can Your Clinical Diagnostics Contract Manufacturer Weather Supply Chain Challenges?
Supply chain security and transparency is a key part of the risk mitigation strategy of companies manufacturing clinical diagnostic assays. Prior to the COVID-19 crisis, complex global supply chains carefully balanced capacity with demand while cost-cutting initiatives pushed towards lower cost raw material providers located in different geographies.
10 Strategic Considerations When Outsourcing Production of In Vitro Diagnostics
The choice of whether to outsource production of an in vitro diagnostic (IVD) or invest and develop inhouse capabilities is a foundational business decision. Capacity, capabilities and resources must all be assessed to determine the best course of action.
Best Practices for Biobanks and Biorepositories
Biobanks and biorepositories play a crucial role in medical research by offering robust, readily available and even rare biospecimen samples for clinical, biomedical and research studies.
Quality Control Steps for Viral Detection and Sequencing
With the onset of the SARS-CoV-2 outbreak in 2019, fast and high-throughput identification and detection of the virus quickly became a necessity to aid in the understanding of where and how fast the virus was spreading. Sequencing is necessary not only for viral detection, but to trace, monitor and identify new variants.
Improved RT-qPCR Could Transform Diagnostics
Download this whitepaper to discover how to overcome the limitations of PCR testing, how RT-qPCR will impact diagnostics both in lab and at point of care and how RT-qPCR is driving new methods and applications.
Advancing the Development of Therapeutics Against Infectious Diseases
Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as
Pharma Efficiencies, Data Compliance and Weighing Excellence
With time a precious commodity and ever-increasing regulatory scrutiny, pharmaceutical laboratories are always on the lookout for simple solutions to make their routine tasks easier.